References

Aho K & Kurki P (1994) Seropositive versus seronegative rheumatoid arthritis - Time for a new definition. J Rheumatol 21:388-90.

Aho K, Palosuo T, Kurki P (1994) Marker antibodies of rheumatoid arthritis: Diagnostic and pathogenetic implications. Semin Arthritis Rheum 23:379-87.

Aho K, Palosuo T, Lukka M, Kurki P, Isomäki H, Kautiainen H & von Essen R (1999) Antifilaggrin antibodies in recent-onset arthritis. Scand J Rheumatol 28: 113-16.

Aho K, Palosuo T, Raunio V, Puska P, Aromaa A & Salonen JT (1985) When does rheumatoid disease start? Arthritis Rheum 28: 485-9.

Aho K, Tuomi T, Palosuo T, Kaarela K, von Essen R & Isomäki H (1989) Is seropositive rheumatoid arthritis becoming less severe? Clin Exp Rheumatol 7:287-90.

Amos RS, Constable TJ, Crockson RA, Crockson AP & McConkey B (1977) Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes. Br Med J 1:195-7.

Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL & Hunder GG (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-24.

Aroso Dias A, Lopes Vaz A, Hargreaves M, Afonso C, Araujo D & Bravo T (1989) Biomarks in secondary osteoporosis. Clin Rheumatol 8(suppl 2):89-94.

Aruga A, Kolzumi M, Hotta R, Takahashi S & Ogata E (1997) Usefulness of bone metabolic markers in the diagnosis and follow-up of bone metastasis from lung cancer. Br J Cancer 76:760-4.

Barwell H (1865) In: Diseases of the joints. Hardwicke, London.

Bettica P, Taylor AK, Talbot J, Moro L, Talamini R & Baylink DJ (1996) Clinical performances of galactosyl hydroxylysine, pyridinoline, and deoxypyridinoline in postmenopausal osteoporosis. J Clin Endocrinol Metab 81:542-6.

Blackburn WD Jr (1994) Validity of acute phase proteins as markers of disease activity. J Rheumatol 21(suppl 42):9-13.

Blumsohn A, Hannon RA, Al-Dehaimi AW & Eastell R (1994) Short-term intraindividual variability of markers of bone turnover in healthy adults. J Bone Miner Res 9(suppl 1):S153.

Brower AC (1990) Use of the radiograph to measure the course of rheumatoid arthritis. Arthritis Rheum 33:316-24.

Bull BS, Farr M, Meyer PJ & Stuart J (1989) Efficacy of tests used to monitor rheumatoid arthritis. Lancet 2:965-7.

Carey DE, Goldberg B, Ratzan SK, Rubin KR & Rowe DW (1985) Radioimmunoassay for type I procollagen in growth hormone deficient children before and during treatment with growth hormone. Pediatric Res 19:8-11.

Cormier C (1995) Markers of bone metabolism. Curr Opin Rheumatol 7:243-8.

Cortet B, Flipo R-M, Pigny P, Duquesnoy B, Boersma A & Marchandise X (1998) Delcambre B. Is bone turnover a determinant of bone mass in rheumatoid arthritis? J Rheumatol 25:2339-44.

Cunningham JL, Fordman JN, Hewitt TA & Speed CA (1996) Ultrasound velocity and attenuation at different skeletal sites compared with bone mineral density measured using dual energy x-ray absorptiometry. Br J Radiol 69:25-32.

Dawes PT, Fowler PD, Clarke S Fisher J, Lawton A & Shadforth MF (1986) Rheumatoid arthritis: treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression. Br J Rheumatol 25:44-49.

Duboeuf F, Pommet R, Meunier PJ & Delmas PD (1994) Dual-energy X-ray absorptiometry of the spine in anteroposterior and lateral projections. Osteoporosis Int 4:110-6.

Eastell R, Delmas PD, Hodgson SF, Eriksen EF, Mann KG & Riggs BL (1988) Bone formation rate in older normal women: concurrent assessment with bone histomorphometry, calcium kinetics, and biochemical markers. J Clin Endocrinol Metab 67:741-8.

Eberhardt KB, Rydgren LC, Pettersson H & Wollheim FA (1990c) Early rheumatoid arthritis - onset, course, and outcome over 2 years. Rheumatol Int 10:135-142.

Elomaa I, Virkkunen P, Risteli L & Risteli J (1992) Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma. Brit J Cancer 66:337-41.

Emery P (1997) Prognosis in inflammatory arthritis: The value of HLA genotyping and the oncological analogy. J Rheumatol 24:1436-42.

von Essen R, Kurki P, Isomäki H, Okubo S, Kautiainen H & Aho K (1993) Prospects for an additional laboratory criterion for rheumatoid arthritis. Scand J Rheumatol 22:267-72.

Everts V, van der Zee E, Creemers L & Beertsen W (1996) Phagocytosis and intracellular digestion of collagen, its role in turnover and remodelling. Histochem J 28:229-45.

Eyre DR, Paz MA & Gallop PM (1984) Cross-linking in collagen and elastin. Annu Rev Biochem 53:717-748.

Ezaki I, Okada M, Yoshikawa Y, Fujikawa Y, Hashimoto M, Otsuka M, Nomura T, Yamamoto K, Watanabe T, Shingu M & Nobunaga M (1996) Human monoclonal rheumatoid factors augment arthritis in mice by the activation of T cells. Clin Exp Immunol 104:474-82.

Fairney A, Patel KV, Hollings NP & Seifert MH (1990) Abnormal osteocalcin binding in rheumatoid arthritis. Ann Rheum Dis 49:229-30.

Fex E, Eberhardt K & Saxne T (1997) Tissue-derived macromolecules and markers of inflammation in serum in early rheumatoid arthritis: Relationship to development of joint destruction in hands and feet. Br J Rheumatol 36:1161-5.

Fex E, Jonsson K, Johnson U & Eberhardt K (1996) Development of radiographic damage during the first 5-6 years of rheumatoid arthritis: a prospective follow-up study of a Swedish cohort. Br J Rheumatol 35:1106-15.

Fisher L, McBride O, Termine J & Young M (1990) Human bone sialoprotein: deduced protein sequence and chromosomal localization. J Biol Chem 265:2347-51.

Fries JF, Spitz P, Kraines RG, Holman HR (1980) Measurement of patients outcome in arthritis. Arthritis Rheum 23:137-45.

Forslind K, Eberhardt K, Jonsson A, Saxne T (1992) Increased serum concentrations of cartilage oligomeric matrix protein. A prognostic marker in early rheumatoid arthritis. Br J Rheumatol 31:593-8.

Gabriel SE & Luthra HS (1988) Rheumatoid arthritis: can the long-term outcome be altered? Mayo Clin Proc 63:58-68.

Garnero P & Delmas PD (1993) Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. J Clin Endocrinol Metab 77:1046-53.

Garnero P, Shih WJ, Gineyts E, Karpf DB & Delmas PD (1994) Comparison of new biochemical markers of bone turnover in late post-menopausal osteoporotic women in response to alendronate therapy. J Clin Endocrinol Metab 79:1693-700.

Gevers G, Devos P, de Roo M & Dequeker J (1986) Increased levels of osteocalcin (serum bone Gla-protein) in rheumatoid arthritis. Br J Rheumatol 25:260-2.

Gough A, Lilley J, Eyre S, Holder R & Emery P (1994) Generalised bone loss in patients with early rheumatoid arthritis. Lancet 344:23-7.

Greenwald RA (1996) Monitoring collagen degradation in patients with arthritis. The search for suitable surrogates. Arthritis Rheum 39:1455-65.

Gressner AM & Neu H-H (1984) N-terminal procollagen peptide and β 2-microglobulin in synovial fluids from inflammatory and non-inflammatory joint diseases. Clin Chim Acta 141:241-5.

Hagiwara s, Yang S-O, Gl¸er CC, Bendavid E & Genant HK (1994) Noninvasive bone mineral density measurement in the evaluation of osteoporosis. Rheum Dis Clin North Am 20:651-65.

Hakala M, Pöllänen R & Nieminen P (1993a) The ARA 1987 revised criteria select patients with clinical rheumatoid arthritis from a population based cohort of subjects with chronic rheumatic diseases registered for drug reimbursement. J Rheumatol 20:1674-8.

Hakala M, Risteli L, Manelius J, Nieminen P, Risteli J (1993b) Increased type I collagen degradation correlates with disease severity in rheumatoid arthritis. Ann Rheum Dis 52:866-9.

Hakala M, Silvennoinen-Kassinen S, Ikäheimo I, Isosomppi J & Tiilikainen A (1997) HLA markers in a community-based rheumatoid arthritis series. Ann Med 29:291-6.

Harris ED Jr (1997) Rheumatoid synovium: Complex, and more than the sum of its parts. In: Rheumatoid Arthritis, 1st edn. W.B. Saunders Company, Philadelphia.

Hassager C, Risteli J, Risteli L & Christiansen C (1994) Effect of the menopause and hormone replacement therapy on the carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen. Osteoporosis Int 4:349-52.

van der Heijde DMFM (1991) Disease activity and outcome in rheumatoid arthritis. A methodological study. PhD thesis, University of Nijmegen.

Heliövaara M, Aho K, Aromaa A, Knekt P & Reunanen A (1993) Smoking and risk of rheumatoid arthritis. J Rheumatol 20:1830-5.

Hørslev-Petersen K, Bentsen KD, Engström-Laurent A, Junker P, Halberg P, Lorenzen I (1988a) Serum amino terminal type III procollagen and serum hyaluronan in rheumatoid arthritis: relation to clinical and serological parameters of inflammation during 8 and 24 months’ treatment with levamisole, penicillamine, or azathioprine. Ann Rheum Dis 47:116-26.

Hørslev-Petersen K, Bentsen KD, Junker J & Lorenzen I (1986) Serum amino-terminal type III procollagen peptide in rheumatoid arthritis. Relationship to disease activity, treatment, and development of joint erosions. Arthritis Rheum 29:592-8.

Hørslev-Petersen K, Saxne T, Haar D, Thomsen BS, Bentsen KD, Junker P & Lorenzen I (1988b) The aminoterminal-type-III procollagen peptide and proteoglycans in serum and synovial fluid of patients with rheumatoid arthritis or reactive arthritis. Rheumatol Int 8:1-9.

Isomäki HA (1987) An epidemiologically based follow-up study of recent arthritis: incidence, outcome and classification. Clin Rheumatol 6(suppl 2):53-9.

Jensen LT, Henriksen JH, Olesen HP, Risteli J & Lorenzen I (1993) Lymphatic clearance of synovial fluid in conscious pigs: the aminoterminal propeptide of type III procollagen. Eur J Clin Invest 23:778-84.

Jergas M & Genant HK (1993) Current methods and recent advances in the diagnosis of osteoporosis. Arthritis Rheum 36:1649-62.

Johnston CC, Slemenda CW & Melton LJ (1991) Clinical use of bone densitometry. N Engl J Med 324:1105-9.

Kanis J (1994) In: Kanis (ed) Ostoporosis, 1st edn. Blackwell Science Ltd, Cornwall.

Kaipiainen-Seppänen O (1996) Incidence of chronic inflammatory rheumatic diseases in Finland during 1975-1990. Doctoral thesis. Kuopio University Publications. Medical sciences 117. Kuopio, Finland.

Keitel W, Hoffman H, Weber G, Krieger U (1971) Ermittlung der prozentualen Funktionsminderung der Gelenke durch einen Bewegungsfunktionstest in der Rheumatologie. DeutschGesundheitswesen 1901-3.

Kellgren JH (1966) Epidemiology of rheumatoid arthritis. Arthritis Rheum 8:658-74.

Kotaniemi A, Isomäki H, Hakala M, Risteli L & Risteli J (1994) Increased type I collagen degradation in early rheumatoid arthritis. J Rheumatol 21:1593-6.

Kröger H & Laitinen K (1992a) Bone mineral density measured by dual energy X-ray absorptiometry in normal men. Eur J Clin Invest 22:454-60.

Kröger H, Heikkinen J, Laitinen K, Kotaniemi A (1992b) Dual-energy X-ray absorptiometry in normal women: a cross-sectional study of 717 Finnish volunteers. Osteoporos Int 2:135-40.

Kröger H, Honkanen R, Saarikoski S, Alhava E (1994) Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis – a population based study. Ann Rheum Dis 53: 18-23.

Kröger H, Risteli J, Penttilä I, Alhava E (1993) Serum osteocalcin and carboxyterminal propeptide of type I procollagen in rheumatoid arthritis. Ann Rheum Dis 52:338-42.

Kushner I (1991) C-reactive protein in rheumatology. Arthritis Rheum 34:1065-8.

Larsen A, Dale K, Eek M (1977) Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn (Stockh) 18:481-91.

Laugier P, Droin P, Laval-Jeantet AM & Berger G (1997) In vitro assessment of the relationship between acoustic properties and bone mass density of the calcaneus by comparison of ultrasound parametric imaging and quantitative computed tomography. Bone 20:157-65.

Laurent TC, Frazer JRE, Laurent UBG, Engström-Laurent A (1995) Hyaluronan in inflammatory joint disease. Acta Orthop Scand 66(suppl. 266):116-20.

Levis S & Altman R (1998) Bone densitometry. Clinical considerations. Arthritis Rheum 41:577-87.

Luukkainen R, Alanaatu A, Kaarela K & Huhtala H (1993) Predictive value of synovial fluid analysis in rheumatoid arthritis. A 7.5-year follow-up study. Eur J Med 5:284-6.

Luukkainen R, Hakala M, Sajanti E, Huhtala H, Yli-Kerttula U & Hämeenkorpi R (1992) Predictive value of synovial fluid analysis in estimating the efficacy of intra-articular corticosteroid injections in patients with rheumatoid arthritis. Ann Rheum Dis 51:874-6.

Luukkainen R, Kaarela K, Huhtala H, Auerma K & Merilahti-Palo R (1989) Prognostic significance of synovial fluid analysis in rheumatoid arthritis. Ann Med 21:269-71.

Luukkainen R, Söderström K-O, Huhtala H (1999) Relationship between synovial fluid cells and grade of inflammation in synovium in patients with arthritis. Scand J Rheumatol 28; 198 (­Abstract).

Maeda S, Sawai T, Uzuki M, Takahashi Y, Omoto H, Seki M & Sakurai M (1995) Determination of interstitial collagenase (MMP-1) in patients with rheumatoid arthritis. Ann Rheum Dis 54:970.

Mallya RK, de Beer FC, Berry H, Hamilton EDB, Mace BEW & Pepys MB (1982) Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentrations of C-reactive protein and erythrocyte sedimentation rate. J Rheumatol 9:224-8.

Masi AT & Feigenbaum SL (1983) Seronegative rheumatoid arthritis. Fact or fiction? Arch Intern Med 143:2167-72.

Masi AT, Maldonado-Cocco JA, Kaplan SB, Feigenbaum SL & Chandler RW (1976) Prospective study of the early course of rheumatoid arthritis in young adults: comparison of patients with and without rheumatoid factor positivity at entry and identification of variables correlating with outcome. Semin Arthritis Rheum 5:299-326.

Mazess RB, Collick B, Trempe J, Barden H & Hanson J (1989) Performance evaluation of a dual-energy x-ray bone densitometer. Calcif Tissue Int 44:228-32.

McConkey B, Crockson RA & Crockson AP (1972) The assessment of rheumatoid arthritis. Q J Med 41:115-25.

McDonald JN & Levick JR (1992) Evidence for simultaneous bidirectional fluid flux across synovial lining in knee joints of anaesthetized rabbits. Exp Physiol 77:513-5.

Melkko J, Kauppila S, Risteli L, Haukipuro K, Jukkola A & Risteli J (1996) Immunoassay for the intact aminoterminal propeptide of human type I procollagen (PINP). Clin Chem 42:947-54.

Murphy G & Hembry RM (1992) Proteinases in rheumatoid arthritis. J Rheumatol 19(suppl 32):61-4.

Månsson B, Carey D, Alini M, Ionescu M, Rosenberg LC & Poole AR (1995) Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism. J Clin Invest 95:1071-7.

Månsson B, Geborek P & Saxne T (1997) Cartilage and bone macromolecules in knee joint synovial fluid in rheumatoid arthritis; relation to development of knee or hip joint destruction. Ann Rheum Dis 56:91-6.

Möttönen T, Hannonen P, Leirisalo-Repo M, Nissilä M, Kautiainen H, Korpela M, Laasonen L, Julkunen H, Luukkainen R, Vuori K, Paimela L, Blåfield H, Hakala M, Ilva K, Yli-Kerttula U, Puolakka K, Järvinen P, Hakola M, Piirainen H, Ahonen J, Pälvimäki I, Forsberg S, Koota K & Friman C for the FIN-RACo trial Group (1999) Comparison of combination therapy with with single-drug therapy in early rheumatoid arthritis: a randomised trial. Lancet 353:1568-73..

Nykänen M, Palosuo T, Aho K, Sahi K & von Essen R (1993) Improved immunoturbidimetry for rheumatoid factor testing. J Clin Pathol 46:1065-6.

Otterness IG (1994) The value of C-reactive protein measurement in rheumatoid arthritis. Semin Arthritis Rheum 24:91-104.

Paimela L, Heiskanen A, Kurki P, Helve T & Leirisalo-Repo M (1991) Serum hyaluronate level as a predictor of radiologic progression in early rheumatoid arthritis. Arthritis Rheum 7:815-21.

Paimela L, Leirisalo-Repo M, Risteli L, Hakala M, Helve T & Risteli J (1994) Type I collagen degradation product in serum of patients with early rheumatoid arthritis: relationship to disease activity and radiological progression in a 3-year follow-up. Br J Rheumatol 33:1012-6.

Paimela L, Palosuo T, Leirisalo-Repo M, Helve T, Aho K (1995) Prognostic value of quantitative measurement of rheumatoid factor in early rheumatoid arthritis. Br J Rheumatol 34:1146-50.

Partiff AM, Simon LS, Villanueva AR & Krane SM (1987) Procollagen type I carboxy-terminal extension in serum as a marker of collagen biosynthesis in bone. Correlation with iliac bone formation rates and comparison with alkaline phosphatase. J Bone Miner Res 2:427-36.

Peel N & Eastell R (1993) Measurement of bone mass and turnover. Baillieres Clin Rheumatol 7:479-98.

Peel N, Eastell R & Russell G (1992) Markers of bone and collagen breakdown in early inflammatory arthritis. Baillieres Clin Rheumatol 6:351-72.

Poole AR (1994) Immunochemical markers of joint inflammation, skeletal damage and repair: where are we now? Ann Rheum Dis 53:3-5.

Reid KBM (1982) Proteins containing collagen sequences. In: Weiss & Jayson (eds) Collagen in health and disease, 1st edn. Churchill Livingstone, Edinburgh.

Resnick D & Niwayama G (1995) Rheumatoid arthritis and seronegative spondylarthropathies: radiographic and pathologic concepts. In: Resnick D, Niwayama G (eds) Diagnosis of bone and joint disorders, 3rd edn. WB Saunders, Philadelphia.

Richardson C & Emery P (1996) Laboratory markers of disease activity. J Rheumatol 44(suppl):31-3.

Riordan J & Dieppe P (1989) Arthritis of the glenohumeral joint. Bailliere’s Clin Rheumatol 3: 607-25.

Risteli J, Niemi S, Trivedi P, Mäentausta O, Mowat AP & Risteli L (1988) Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin Chem 34:715-8.

Risteli J, Elomaa I, Niemi S, Novamo A & Risteli L (1993) Radioimmunoassay for the pyridinoline cross-linked carboxyterminal telopeptide of type I collagen: A new serum marker of bone collagen degradation. Clin Chem 39:635-40.

Risteli J & Risteli L (1999) Dynamics of bone and cartilage metabolism: principles and clinical applications. In: Seibel MJ, Robins SP, Bilezikian JP (eds) Products of bone collagen metabolism. Academic Press, London, Chapter 19, in press.

Risteli L (1993) Assay of collagen metabolism. Orion Diagnostica, Helsinki.

Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos TG, Grieveson P, Buchanan WW (1968) Clinical studies with articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 37:393-406.

Robins SP (1982) Turnover and crosslinking of collagen. In: Weiss JB & Jayson MIV (eds) Collagen in health and disease. Churchill Livingstone, Edinburg, p.160-178.

Robins SP, Stewart P, Astbury C & Bird HA (1986) Measurement of the cross-linking compound, pyridinoline, in urine as an index of collagen degradation in joint diseases. Ann Rheum Dis 45:969-73.

Saarto T, Blomqvist C, Risteli J, Risteli L, Sarna S & Elomaa I (1998) Aminoterminal propeptide of type I procollagen (PINP) correlates to bone moss and predicts the efficacy of antiresorptive therapy in pre- and postmenopausal non metastatic breast cancer patients. Br J Cancer 78:240-5.

Sambrook P, Ansell B, Foster S, Gumpel J, Hesp R & Reeve J (1985a) Bone turnover in early rheumatoid arthritis. 1. Biochemical and kinetic indices. Ann Rheum Dis 44:575-9.

Sambrook P, Ansell B, Foster S, Gumpel J, Hesp R & Reeve J (1985b) Bone turnover in early rheumatoid arthritis. 2: Longitudinal bone density studies. Ann Rheum Dis 44:580-4.

Sambrook P, Eisman J, Yeates M, Pocock N & Champion G (1986) Osteoporosis in rheumatoid arthritis: Safety of low dose corticosteroids. Ann Rheum Dis 45:950-3.

Sambrook P, Cohen M, Eisman J, Pocock M, Champion J & Yeates M (1989) Effects of low dose corticosteroids on bone mass in rheumatoid arthritis: A longitudinal study. Ann Rheum Dis 48:535-8.

Saraux A, Allain J, Guedes C, Valls I, Baron D, Youinou P & Le Goff P (1997) Clinical, laboratory and radiographic features of rheumatoid arthritis with and without nodules. Rev Rheum (Engl Ed) 64:11-17.

Sassi M-L, Eriksen H, Risteli L, Niemi S, Mansell J, Gowen M & Risteli J Immunochemical characterization of the assay for the carboxyterminal telopeptide of human type I collagen (ICTP). Loss of antigenicity by treatment with cathepsin K. Submitted.

Savolainen E-R, Goldberg B, Leo MA, Valez M & Lieber CS (1983) Diagnostic value of serum procollagen peptide measurements in alcoholic liver disease. Alcohol Clin Exp Res 8:384-9.

Saxne T, Wollheim F, Petterson H & Heinegård D (1987) Proteoglycan concentration in synovial fluid: predictor of future cartilage destruction in rheumatoid arthritis? Br Med J 295:1447-8.

Saxne T, Zunino L & Heinegård D (1995) Increased release of bone sialoprotein into synovial fluid reflects tissue destruction in rheumatoid arthritis. Arthritis Rheum 38:82-90.

Scheiber LB & Torregrosa L (1998) Evaluation and Treatment of Postmenopausal Osteoporosis. Semin Arthritis Rheum 27:245-61.

Schlemmer A, Hassager C, Jensen SB & Christiansen C (1992) Marked diurnal variation in urinary excretion of pyridinium cross-links in premenopausal women. J Clin Endocrinol Metab 74:476-480.

Schumacher HR Jr (1993) Synovial fluid analysis and synovial biopsy. In: Kelley WN, Harris ED Jr, Rubby S & Sledge CB (eds) Textbook of Rheumatology, 4th edn. Vol.1, W.B. Saunders, Philadelphia, p.562-78.

Scott D, Coulton B, Bacon P & Popert A (1985) Methods of x-ray assessment in rheumatoid arthritis: a re-evaluation. Br J Rheumatol 24:31-9.

Seibel MJ, Duncan A & Robins SP (1989) Urinary hydroxypyridinium crosslinks provide indices of cartilage and bone involvement in arthritic diseases. J Rheumatol 16:964-70.

Seibel MJ, Robins SP & Bilezikian JP (1992) Urinary pyridinium crosslinks of collagen. Specific markers of bone resorption in metabolic bone disease. Trends Endocrinol Metab 3:263-70.

Seyedin SM, Kung VT, Daniloff YN, Hesley RP, Gomez B, Nielsen LA, Rosen HN & Zuk RF (1993) Immunoassay for urinary pyridinoline: the new marker of bone resorption. J Bone Miner Res 8:635-41.

Sharp CA, Evans SF, Risteli L, Risteli J, Worsfold M & Davie MWJ (1996) Effects of low and conventional dose transcutaneous HRT over 2 years on bone metabolism in younger and older postmenopausal women. Eur J Clin Invest 26: 763-71.

Sharp JT (1989) Radiologic assessment as an outcome measure in rheumatoid arthritis. Arthritis Rheum 33:316-24.

Shenstone BD, Mahmoud A, Woodward R, Elvins D, Palmer R, Ring EF & Bhalla AK (1994) Longitudinal bone mineral density changes in early rheumatoid arthritis. Br J Rheumatol 33:541-5.

Shmerling RH (1994) Synovial fluid analysis. A critical reappraisal. Rheum Dis Clin North Am 20:503-12.

Simon LS, Krane SM, Wortman PD, Krane IM & Kovitz KL (1984) Serum levels of type I and III procollagen fragments in Paget’s disease of bone. J Clin Endocrinol Metab 58:110-20.

Smolen JS, Steiner G (1998) Are autoantibodies active players or epiphenomena? Curr Opin Rheumatol 10:201-6.

Star V & Hochberg M (1994) Osteoporosis in patients with rheumatic diseases. Rheum Dis Clin North Am 3:561-17.

Stastny P (1974) Mixed lymphocyte culture typing cells from patients with rheumatoid arthritis. Tissue Antigens 4:571-9.

Stastny P (1978) Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med 298:869-71.

St. Clair E, Moak S, Wilkinson W, Sanders L, Lang T, Greenwald R (1998) A cross sectional analysis of 5 different markers of collagen degradation in rheumatoid arthritis. J Rheumatol 25:1472-9.

Suvanto-Luukkonen E, Risteli L, Sundström H, Penttinen J, Kauppila A & Risteli J (1997) Comparison of three serum assays for bone collagen formation during postmenopausal estrogen-progestin therapy. Clin Chim Acta 266:105-116.

Taubman MB, Goldberg B & Sherr CJ (1974) Radioimmunoassay for human procollagen. Science 186:1115-7.

Taylor AK, Lueken SA, Libanati C & Baylink BJ (1994) Biochemical markers of bone turnover for the clinical assessment of bone metabolism. Rheum Dis Clin North Am 20:589-607.

Vincent MP, Clark IM & Brinkerhoff CE (1994) Using inhibitors of metalloproteinases to treat arthritis. Easier said than done? Arthritis Rheum 37:1115-26.

Weisman MH, Orth RW, Catherwood BD, Manolagas SC & Deftos LJ (1986) Measures of bone loss in rheumatoid arthritis. Arch Int Med 146:701-4.

Whicher JT & Dieppe PA (1985) Acute phase proteins. Clin Immunol Allergy 5:425-46.

Wolfe F (1997) Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis. J Rheumatol 24:1477-85.

Wolfe F, Kleinheksel SM, Cathey MA, Hawley DJ, Spitz PW, Fries JF (1988) The Clinical value of the Stanford Health Assessment Questionnaire Functional Disability Index in patients with rheumatoid arthritis. J Rheumatol 15:1480-8.

Wollheim FA (1994) New insights into joint damage from analysis of released biochemical markers. Br J Rheumatol 33:1-4.

Wollheim FA & Eberhardt KB (1992) The search for laboratory measures of outcome in rheumatoid arthritis. Baillieres Clin Rheumatol 6:69-93.

Wordsworth P & Bell JI (1990) The immunogenetics of rheumatoid arthritis. Curr Opin Rheumatol 2:423-9.

Young A & van der Heijde D (1997) Can we predict aggressive disease? Baillieres Clin Rheumatol 11:27-48.

van Zeben D, Breedveld FC (1996) Prognostic factors in rheumatoid arthritis. J Rheumatol 4(suppl):23-30.